Form 4: Air Products EVP Acquires Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Air Products & Chemicals EVP and General Counsel Matthew Lepore reported the acquisition of 2,107 shares of common stock on December 1, 2025, under a pre-arranged 10b5-1 plan.

Summary

  • Matthew Lepore, Executive Vice President and General Counsel of Air Products & Chemicals, Inc. (APD), reported a change in beneficial ownership.
  • The transaction involved the acquisition of 2,107 shares of Common Stock.
  • The transaction date was December 1, 2025.
  • The acquisition price was $0.0000, indicating it was likely a grant or award rather than an open market purchase.
  • Following this transaction, Matthew Lepore directly beneficially owns 5,578 shares of Common Stock.
  • The transaction was made pursuant to a Rule 10b5-1(c) plan, which allows insiders to set up a pre-arranged plan for buying or selling company stock.

Sentiment

Score: 6

Explanation: The acquisition of shares by an executive, even if a grant, generally indicates alignment of interests and potential confidence in the company's future. The 10b5-1 plan adds transparency to the transaction, making it a neutral to slightly positive signal.

Positives

  • An executive acquiring shares, even if through a grant, can signal confidence in the company's future prospects and aligns management's interests with shareholders.
  • The transaction was conducted under a Rule 10b5-1 plan, which provides transparency and indicates a pre-planned, non-discretionary transaction, mitigating concerns about opportunistic trading.

Negatives

  • The shares were acquired at a price of $0.00, suggesting a grant or award rather than a direct cash purchase, which would typically signal stronger personal conviction in the stock's valuation.

Future Outlook

N/A. This Form 4 filing reports a past transaction and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing details an insider transaction for Air Products & Chemicals, Inc., a leading global supplier of industrial gases. Such transactions are common across industries as part of executive compensation packages and generally reflect individual executive holdings rather than broader industry trends, though they can signal insider confidence in the company's specific trajectory.

Related Party Transactions

  • The reported acquisition of common stock by Matthew Lepore, an executive officer, from Air Products & Chemicals, Inc. is a related party transaction, as it involves a transaction between the company and one of its key management personnel.

Stakeholder Impact

  • Shareholders: The increase in executive ownership aligns management's interests with shareholders, potentially fostering better long-term decision-making. The shares were acquired at $0.00, suggesting a grant which is part of executive compensation and could involve minor dilution if new shares were issued.
  • Employees: No direct impact on employees is indicated by this filing.
  • Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

DateDescription
12/01/2025Date of transaction for the acquisition of common stock by Matthew Lepore.
12/03/2025Date the Form 4 was signed by Andrea I. Rennig as Attorney in Fact for Matthew Lepore.

Recommendation

hold

This Form 4 reports a routine insider acquisition of shares by an executive, likely as part of a compensation package, under a pre-arranged 10b5-1 plan. While it indicates alignment of interests, it does not provide new fundamental information about the company's performance or outlook that would warrant a change from a 'hold' position based solely on this filing. Investors should consider broader company fundamentals and market conditions.

Keywords

Air Products & Chemicals, APD, Form 4, Insider Transaction, Stock Acquisition, Executive Compensation, Matthew Lepore, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.